PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism endows tumor cells with metabolic flexibility for biosynthesis requirements. Phosphoenolpyruvate carboxykinase 1 (PCK1), a key enzyme in the gluconeogenesis pathway, is downregulated in hepatocellular carcinoma (HCC) and predicts poor prognosis. Overexpression of PCK1 has been shown to suppress liver tumor growth, but the underlying mechanism remains unclear. mRNA and protein expression patterns of PCK1, AMPK, pAMPK, and the CDK/Rb/E2F pathway were determined using qRT-PCR and western blotting. Cell proliferation ability and cell cycle were assessed by MTS assay and flow cytometric analysis. The effect of PCK1 on tumor growth was examined in xenograft implantation models. Both gain and loss-of-function experiments demonstrated that PCK1 deficiency promotes hepatoma cell proliferation through inactivation of AMPK, suppression of p27 Kip1 expression, and stimulation of the CDK/Rb/E2F pathway, thereby accelerating cell cycle transition from the G1 to S phase under glucose-starved conditions. Overexpression of PCK1 reduced cellular ATP levels and enhanced AMPK phosphorylation and p27 Kip1 expression but decreased Rb phosphorylation, leading to cell cycle arrest at G1. AMPK knockdown significantly reversed G1-phase arrest and growth inhibition of PCK1-expressing SK-Hep1 cells. In addition, the AMPK activator metformin remarkably suppressed the growth of PCK1-knockout PLC/PRF/5 cells and inhibited tumor growth in an orthotropic HCC mouse model. This study revealed that PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27 Kip1 axis and supports a potential therapeutic and protective effect of metformin on HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, research in the past decades indicated that these enzymes have a moonlighting function in phosphorylating various proteins that regulate many pathways ranging from cell‐cycle progression and proliferation to apoptosis, autophagy and T‐cell activation.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [247]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
AMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,061
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 7×
“Immunoblot assays showed that protein levels of LKB1 and CaMKK2 were not affected upon modulation of PCK1 expression (Fig.”
BackgroundInfluentialHawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
AMPK: Sensing Glucose as well as Cellular Energy Status
Lin, S.-C., & Hardie, D. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.009 · Cited by 1,191 · cited 2×
“(AMPK) is a central cellular sensor of adenine nucleotides that plays a key role in sensing cellular energy availability and regulating metabolic adaptation pathways [11, 12].”
BackgroundReprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S.-H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 995
Cited by
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Gluconeogenesis in cancer cells – Repurposing of a starvation-induced metabolic pathway?
Grasmann, G., Smolle, E., Olschewski, H., & Leithner, K. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.006 · Cited by 237
Ye, Q., Liu, Y., Zhang, G., Deng, H., Wang, X., Tuo, L., Chen, C., Pan, X., Wu, K., Fan, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37142-3 · Cited by 168
Self-citationJin, X., Chen, C., Liu, R., Gou, D., Chang, L., Deng, H., Gao, Q., Zhang, W., Tuo, L., Pan, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144703 · Cited by 126
“Previously, we reported that PCK1 activates AMP-activated protein kinase (AMPK) upon glucose deprivation in HCC (24).”
BackgroundInfluentialSelf-citationKosti, A., Araujo, P. R. D., Li, W.-Q., Guardia, G. D. A., Chiou, J., Yi, C., Ray, D., Meliso, F. M., Li, Y.-M., Delambre, T., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02115-y · Cited by 121
“PCK1 is downregulated in hepatocellular carcinoma (HCC) and clear cell renal cell carcinoma and its reduced expression predicts poor prognosis [56, 57].”
Background
Metadata
- Authors
- Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., Wang, K., & Tang, N.
- Affiliations
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Corresponding author
- Huang, Ailong
- Wang, Kai
- Tang, Ni
- Venue
- Journal of Experimental & Clinical Cancer Research
- Published
- 2019-02-04
- Volume
- 38
- Issue
- 1
- Pages
- 50-50
- ISSN
- 0392-9078 (ISSN-L)
- 1756-9966
- PMC
- PMC6360696
- OpenAlex
- W2921283762
- Cited by
- 84
- References
- 52
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 15 · 2020: 8 · 2019: 5
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81602417, 81572683, 81371827, 81872270,31171307, 81471946,81661148057, 81671997)
- Natural Science Foundation of Chongqing (cstc2015jcyjBX0011, cstc2018jcyjAX0254)
- Department of S and T for Social Development (2017ZX10202203-004, 2012ZX10002005-003-002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PCK1, hepatocellular carcinoma, AMPK, p27, cell cycle progression, cell proliferation, gluconeogenesis, glucose metabolism, metformin, G1 cell cycle arrest, tumor growth
- MeSH terms
- Animals, Calcium-Binding Proteins, Glucose, Carcinoma, Hepatocellular, Humans, Hypoglycemic Agents, Liver Neoplasms, Male, Metformin, Phosphoenolpyruvate Carboxykinase (GTP), Down-Regulation, Up-Regulation, Cyclin-Dependent Kinases, Xenograft Model Antitumor Assays, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Cell Proliferation, E2F Transcription Factors, Mice, AMP-Activated Protein Kinases, Gene Knockdown Techniques, G1 Phase Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. https://app.cochat.ai/papers/10.1186/s13046-019-1029-y
- The paper
- Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., Wang, K., & Tang, N. (2019). PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-019-1029-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.